Aion Therapeutic Announces Change of Auditor
Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that the Company's audit committee and board of directors approved a change in the Company's auditors from DNTW Toronto LLP (the "Former Auditor") to Horizon Assurance LLP (the "Successor Auditor"), effective June 6, 2025.There were no reservations in the Former Auditor's reports for the two most recently completed fiscal years or for any period after the most recently completed period...
2025-06-06 5:38 PM EDT
Aion Therapeutic Provides Update on Non-Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - December 6, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") provides an update on its previously announced private placement. Further to the news release dated October 21, 2024, the Company intends to complete a non-brokered private placement offering (the "Offering") of up to 33,333,333 units ("Units"), at a price of $0.015 per Unit, for total gross proceeds of up to approximately $500,000. The Company anticipates that the Offering will close in the...
2024-12-06 5:30 PM EST
Aion Therapeutic Announces Revocation of MCTO
Toronto, Ontario--(Newsfile Corp. - November 13, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it has received an order from the British Columbia Securities Commission (the "BCSC") revoking the management cease trade order (the "MCTO") previously granted by the BCSC on August 29, 2024.As previously announced, the MCTO was granted by the BCSC at the Company's request on August 29, 2024, due to delays in filing the Company's annual audited consolidated...
2024-11-13 6:48 PM EST
Aion Therapeutic Provides Bi-Weekly MCTO Status Update
Toronto, Ontario--(Newsfile Corp. - October 24, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing this bi-weekly update on the status of its management cease trade order issued on August 29, 2024 (the "MCTO"), by its principal regulator, the British Columbia Securities Commission (the "BCSC"), under National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). The Company announced on August 14, 2024 (the "Default Announcement"), that it expected to be unable to file its annual...
2024-10-24 5:00 PM EDT
Aion Therapeutic Hires CRO for Toppen Health; Announces Director Resignation
Toronto, Ontario--(Newsfile Corp. - October 23, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company"), through its water filtration subsidiary, Toppen Health, Inc. ("Toppen" or "Toppen Health"), is excited to announce the appointment of Charles Freihofer as its new Chief Revenue Officer ("CRO"). Mr. Freihofer joined Toppen in mid-September to lead the organization's renewed focus on revenue and earnings. The Company is also announcing that Larry Horwitz resigned as a director effective Friday, October 18, 2024. The...
2024-10-23 7:55 AM EDT
Aion Therapeutic Announces Non- Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - October 21, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it intends to complete a non-brokered private placement offering (the "Offering") of up to 33,333,333 units ("Units"), at a price of $0.015 per Unit, for total gross proceeds of up to approximately $500,000.Each Unit will consist of one common share ("Share") and one half of one common share purchase warrant ("Warrant"). Each full Warrant will be exercisable...
2024-10-21 5:54 PM EDT
Aion Therapeutic Provides Bi-Weekly MCTO Status Update
Toronto, Ontario--(Newsfile Corp. - October 10, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing this bi-weekly update on the status of its management cease trade order issued on August 29, 2024 (the "MCTO"), by its principal regulator, the British Columbia Securities Commission (the "BCSC"), under National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). The Company announced on August 14, 2024 (the "Default Announcement"), that it expected to be unable to file its annual...
2024-10-10 4:15 PM EDT
Aion Donates Toppen Water Filtration Solutions to Support Hurricane Helene Relief Efforts
Sandford, Florida--(Newsfile Corp. - October 10, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company"), through its water filtration subsidiary, Toppen Health, Inc. ("Toppen" or "Toppen Health"), announced today that it has donated multiple water filtration systems to Trinity Baptist Church to support Hurricane Helene recovery and relief efforts in western North Carolina.Labeled one of the most deadly hurricanes to hit the United States mainland in over 50 years, Hurricane Helene has left communities in ruin from...
2024-10-10 7:50 AM EDT
Aion Announces CSA Certification for Toppen Water Filtration Solutions
Toronto, Ontario--(Newsfile Corp. - October 8, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company"), through its water filtration subsidiary, Toppen Health, Inc. ("Toppen" or "Toppen Health"), is excited to announce that as of September 26, 2024, certain models of its water filtration solutions have received the Canadian Standards Association ("CSA") Group certification of "Class 6811 43 PLUMBING - DRINKING WATER TREATMENT SYSTEMS - Certified to CSA B483.1."CSA certification and the approval to put the CSA mark...
2024-10-08 7:50 AM EDT
Aion Therapeutic Provides Bi-Weekly MCTO Status Update
Toronto, Ontario--(Newsfile Corp. - September 26, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing this bi-weekly update on the status of its management cease trade order issued on August 29, 2024 (the "MCTO"), by its principal regulator, the British Columbia Securities Commission (the "BCSC"), under National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). The Company announced on August 14, 2024 (the "Default Announcement"), that it expected to be unable to file its annual...
2024-09-26 5:12 PM EDT
Aion Therapeutic Announces Closing of First Tranche of Non-Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - September 20, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its non-brokered private placement offering (the "Offering") of units ("Units") as previously announced on August 23, 2024. In connection with the closing of the First Tranche, the Company Issued 22,000,000 Units at a price of $0.011 per Unit, for total gross proceeds of $242,000. Each Unit consists...
2024-09-20 5:00 PM EDT
Aion Therapeutic Provides Bi-Weekly MCTO Status Update
Toronto, Ontario--(Newsfile Corp. - September 12, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing this bi-weekly update on the status of its management cease trade order issued on August 29, 2024 (the "MCTO"), by its principal regulator, the British Columbia Securities Commission (the "BCSC"), under National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). The Company announced on August 14, 2024 (the "Default Announcement"), that it expected to be unable to file its annual...
2024-09-12 8:45 PM EDT
Aion Therapeutic Announces Grant of Management Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - August 29, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that further to its release issued on August 14, 2024 in respect of its application to the British Columbia Securities Commission (the "BCSC") for a management cease trade order (the "MCTO"), that the BCSC has granted the MCTO, pursuant to which the Company will have until October 28, 2024 to file its annual audited consolidated financial statements for the financial...
2024-08-29 7:58 PM EDT
Aion Therapeutic Announces Non-Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - August 23, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it intends to complete a non-brokered private placement offering (the "Offering") of up to 45,454,545 units ("Units"), at a price of $0.011 per Unit, for total gross proceeds of up to approximately $500,000.Each Unit will consist of one common share ("Share") and one half of one common share purchase warrant ("Warrant"). Each full Warrant will be exercisable...
2024-08-23 4:58 PM EDT
Aion Therapeutic Reports Delay in Filing 2024 Annual Financial Statements
Toronto, Ontario--(Newsfile Corp. - August 14, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that the Company will be unable to file its annual audited consolidated financial statements for the financial year ended April 30, 2024, the related annual management's discussion and analysis and the related CEO and CFO certifications (collectively, the "2024 Financial Disclosure") by August 28, 2024 (the "Filing Deadline") in accordance with the requirements of National Instrument 51-102 - Continuous Disclosure...
2024-08-14 7:13 PM EDT
Aion Therapeutic Secures Licensing Agreement for Molecular Iodine Technology
Toronto, Ontario--(Newsfile Corp. - July 31, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company"), through its water filtration subsidiary, Toppen Health, Inc. ("Toppen"), is excited to announce that it has entered into a license agreement (the "License Agreement") with I2Pure Corp. ("I2Pure") for the worldwide rights to its patented molecular iodine for use in water disinfection applications, enhancing Toppen's advanced water filtration systems.I2Pure is a healthcare technology company focused on leveraging the natural antimicrobial power of...
2024-07-31 5:20 PM EDT
Aion Therapeutic Completes Non-Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - May 17, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it has completed a non-brokered private placement offering (the "Offering") of 50,000,000 units ("Units"), at a price of $0.015 per Unit, for total gross proceeds of $750,000.Each Unit consists of one common share ("Share") and one common share purchase warrant ("Warrant"). Each Warrant will be exercisable to acquire one Share ("Warrant Share") for a period of eighteen...
2024-05-17 5:00 PM EDT
Patent Applications by Toppen Health Transforming Liquid Filtration Effectiveness
Toronto, Ontario--(Newsfile Corp. - May 9, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company"), through its water filtration subsidiary, Toppen Health, Inc. ("Toppen" or "Toppen Health"), is excited to announce that it has filed pivotal patents for technology designed to facilitate maximum filter configuration flexibility when it comes to addressing varying water quality issues. When it comes to industries like healthcare-and specifically dental-where water quality and safety is paramount to patient health and wellbeing, vigorous, repeated,...
2024-05-09 8:23 AM EDT
Aion Therapeutic Announces Proposed Non- Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - April 22, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it plans to complete a non-brokered private placement offering (the "Offering") of up to 50,000,000 units ("Units"), at a price of $0.015 per Unit, for total gross proceeds of up to $750,000.Each Unit consists of one common share ("Share") and one common share purchase warrant ("Warrant"). Each Warrant will be exercisable to acquire one Share ("Warrant Share")...
2024-04-22 5:30 PM EDT
Aion Therapeutic Responds to First-Ever U.S. Drinking Water Standard Making PFAS Removal a Top Priority
Toronto, Ontario--(Newsfile Corp. - April 12, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") and its water filtration subsidiary, Toppen Health, Inc. ("Toppen" or "Toppen Health"), are excited to share that on April 10, 2024, the Biden-Harris Administration in the United States has issued a groundbreaking and first-ever national, legally enforceable drinking water standard to protect communities from exposure to harmful per-and polyfluoroalkyl substances ("PFAS"), also known as "forever chemicals." According to the April 10 release,...
2024-04-12 11:15 AM EDT